Pulmonary Hypertension Drugs Market Research: Global Status & Forecast by Geography, Type & Application 2016-2026


Report ID : RC-65277 Category : Medical Devices
Published Date : May-20 Pages : 102 Format : PDF
Summary

According to 99Strategy, the Global Pulmonary Hypertension Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Pulmonary Hypertension Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions
    Asia Pacific
    North America
    Europe
    South America
    Middle East & Africa

Key Companies
    Bayer?
    GSK?
    Arena?
    Actelion?
    Pfizer?
    United Therapeutics?
    Gilead Sciences?
    Lung Biotechnology PBC

Key Product Type
    Prostacyclin and prostacyclin analogs?
    Endothelin receptor antagonists (ERAs)?
    Phosphodiesterase-5 (PDE-5) inhibitors?
    Soluble guanylate cyclase (sGC) stimulators

Market by Application
    Early-stage Drug Candidates (Phase I & Phase II)
    Late-stage Drug Candidates (Phase III & Registration Phase)

Main Aspects covered in the Report
    Overview of the Pulmonary Hypertension Drugs market including production, consumption, status & forecast and market growth
    2016-2020 historical data and 2021-2026 market forecast
    Geographical analysis including major countries
    Overview the product type market including development
    Overview the end-user market including development
    Impact of Coronavirus on the Industry
Table of Content
1 Industrial Chain Overview
    1.1 Pulmonary Hypertension Drugs Industry
        1.1.1 Overview
                Figure Pulmonary Hypertension Drugs Picture List
        1.1.2 Characteristics of Pulmonary Hypertension Drugs
    1.2 Upstream
        1.2.1 Major Materials
        1.2.2 Manufacturing Overview
    1.3 Product List By Type
        1.3.1 Prostacyclin and prostacyclin analogs?
        1.3.2 Endothelin receptor antagonists (ERAs)?
        1.3.3 Phosphodiesterase-5 (PDE-5) inhibitors?
        1.3.4 Soluble guanylate cyclase (sGC) stimulators
    1.4 End-Use List
        1.4.1 Demand in Early-stage Drug Candidates (Phase I & Phase II)
        1.4.2 Demand in Late-stage Drug Candidates (Phase III & Registration Phase)
    1.5 Global Market Overview
        1.5.1 Global Market Size and Forecast, 2016-2026
                Figure Global Market Size and Forecast with Growth Rate, 2016-2026
        1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026
                Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
        1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026
                Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
        1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026
                Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
2 Global Production & Consumption by Geography
    2.1 Global Production & Consumption
        2.1.1 Global Production
                Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
                Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
                Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
                Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
        2.1.2 Global Consumption
                Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
                Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
                Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
                Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
    2.2 Geographic Production & Consumption
        2.2.1 Production
            2.2.1.1 Asia-Pacific
                Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
                Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
                Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
                Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
            2.2.1.2 North America
                Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
                Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
                Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
                Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
            2.2.1.3 South America
                Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
                Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
                Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
                Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
            2.2.1.4 Europe
                Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
                Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
                Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
                Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
            2.2.1.5 Middle East & Africa
                Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
                Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
                Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
                Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
        2.2.2 Consumption
            2.2.2.1 Asia-Pacific
                Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
                Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
                Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
                Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
            2.2.2.2 North America
                Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
                Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
                Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
                Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
            2.2.2.3 South America
                Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
                Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
                Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
                Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
            2.2.2.4 Europe
                Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
                Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
                Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
                Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
            2.2.2.5 Middle East & Africa
                Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
                Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
                Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
                Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
3 Major Manufacturers Introduction
    3.1 Manufacturers Overview
                Table Major Manufacturers Headquarters and Contact Information
                Table Major Manufacturers Capacity List in 2018
    3.2 Manufacturers List
        3.2.1 Bayer? Overview
                Table Bayer? Overview List
            3.2.1.1 Product Specifications
            3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of Bayer? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.1.3 Recent Developments
            3.2.1.4 Future Strategic Planning
        3.2.2 GSK? Overview
                Table GSK? Overview List
            3.2.2.1 Product Specifications
            3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of GSK? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.2.3 Recent Developments
            3.2.2.4 Future Strategic Planning
        3.2.3 Arena? Overview
                Table Arena? Overview List
            3.2.3.1 Product Specifications
            3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of Arena? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.3.3 Recent Developments
            3.2.3.4 Future Strategic Planning
        3.2.4 Actelion? Overview
                Table Actelion? Overview List
            3.2.4.1 Product Specifications
            3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of Actelion? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.4.3 Recent Developments
            3.2.4.4 Future Strategic Planning
        3.2.5 Pfizer? Overview
                Table Pfizer? Overview List
            3.2.5.1 Product Specifications
            3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of Pfizer? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.5.3 Recent Developments
            3.2.5.4 Future Strategic Planning
        3.2.6 United Therapeutics? Overview
                Table United Therapeutics? Overview List
            3.2.6.1 Product Specifications
            3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of United Therapeutics? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.6.3 Recent Developments
            3.2.6.4 Future Strategic Planning
        3.2.7 Gilead Sciences? Overview
                Table Gilead Sciences? Overview List
            3.2.7.1 Product Specifications
            3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of Gilead Sciences? (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.7.3 Recent Developments
            3.2.7.4 Future Strategic Planning
        3.2.8 Lung Biotechnology PBC Overview
                Table Lung Biotechnology PBC Overview List
            3.2.8.1 Product Specifications
            3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
                Table Pulmonary Hypertension Drugs Business Operation of Lung Biotechnology PBC (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
            3.2.8.3 Recent Developments
            3.2.8.4 Future Strategic Planning
4 Market Competition Pattern
    4.1 Market Size and Sketch
                Figure Global Market Size and Growth Rate, 2016-2020, in Volume
                Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
                Figure Global Competition Sketch Overview
    4.2 Company Market Share
        4.2.1 Global Production by Major Manufacturers
                Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
                Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
                Figure Global Production Volume Share by Manufacturers in 2020, in Volume
                Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
                Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
                Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
        4.2.2 Market Concentration Analysis
    4.3 Market News and Trend
        4.3.1 Merger & Acquisition
        4.3.2 New Product Launch
5 Product Type Segment
    5.1 Global Overview by Product Type Segment
                Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
                Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
    5.2 Segment Subdivision by Product Type
        5.2.1 Market in Prostacyclin and prostacyclin analogs?
            5.2.1.1 Market Size
                Figure Global Market Amount and Growth Rate in Prostacyclin and prostacyclin analogs?, 2016-2020, in USD Million
                Figure Global Market Amount and Growth Rate in Prostacyclin and prostacyclin analogs?, 2016-2020, in Volume
            5.2.1.2 Situation & Development
        5.2.2 Market in Endothelin receptor antagonists (ERAs)?
            5.2.2.1 Market Size
                Figure Global Market Amount and Growth Rate in Endothelin receptor antagonists (ERAs)?, 2016-2020, in USD Million
                Figure Global Market Amount and Growth Rate in Endothelin receptor antagonists (ERAs)?, 2016-2020, in Volume
            5.2.2.2 Situation & Development
        5.2.3 Market in Phosphodiesterase-5 (PDE-5) inhibitors?
            5.2.3.1 Market Size
                Figure Global Market Amount and Growth Rate in Phosphodiesterase-5 (PDE-5) inhibitors?, 2016-2020, in USD Million
                Figure Global Market Amount and Growth Rate in Phosphodiesterase-5 (PDE-5) inhibitors?, 2016-2020, in Volume
            5.2.3.2 Situation & Development
        5.2.4 Market in Soluble guanylate cyclase (sGC) stimulators
            5.2.4.1 Market Size
                Figure Global Market Amount and Growth Rate in Soluble guanylate cyclase (sGC) stimulators, 2016-2020, in USD Million
                Figure Global Market Amount and Growth Rate in Soluble guanylate cyclase (sGC) stimulators, 2016-2020, in Volume
            5.2.4.2 Situation & Development
6 End-Use Segment
    6.1 Global Overview by End-Use Segment
                Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
                Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
    6.2 Segment Subdivision
        6.2.1 Market in Early-stage Drug Candidates (Phase I & Phase II)
            6.2.1.1 Market Size
                Figure Global Market Amount and Growth Rate in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in USD Million
                Figure Global Market Amount and Growth Rate in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in Volume
            6.2.1.2 Situation & Development
        6.2.2 Market in Late-stage Drug Candidates (Phase III & Registration Phase)
            6.2.2.1 Market Size
                Figure Global Market Amount and Growth Rate in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in USD Million
                Figure Global Market Amount and Growth Rate in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in Volume
            6.2.2.2 Situation & Development
7 Market Forecast & Trend
    7.1 Regional Forecast
                Table Global Market Forecast by Region Segment 2021-2026, in Million USD
                Table Global Market Forecast by Region Segment 2021-2026, in Volume
    7.2 Consumption Forecast
        7.2.1 Product Type Forecast
                Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
                Table Global Market Volume by Product Type Segment 2021-2026, in Volume
        7.2.2 End-Use Forecast
                Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
                Table Global Market Volume by End-Use Segment 2021-2026, in Volume
    7.3 Investment Trend
    7.4 Consumption Trend
8 Price & Channel
    8.1 Price and Cost
        8.1.1 Price
        8.1.2 Cost
                Figure Cost Component Ratio
    8.2 Channel Segment
9 Market Drivers & Investment Environment
    9.1 Market Drivers
    9.2 Investment Environment
    9.3 Impact of Coronavirus on the Pulmonary Hypertension Drugs Industry
        9.3.1 Impact on Industry Upstream
        9.3.2 Impact on Industry Downstream
        9.3.3 Impact on Industry Channels
        9.3.4 Impact on Industry Competition
        9.3.5 Impact on Industry Employment
10 Research Conclusion

Sidebar Menu